Novo Nordisk A/S annual earnings per share (EPS) for fiscal TTM was $27.42, an increase of 19.1% from $23.03 in fiscal 2025. All figures are reported results from public filings — no estimates or projections.
| EPS (annual) | TTM → 2026-03-31 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (EPS) | $27.42 | $23.03 | $22.63 | $18.62 | $12.22 | $10.37 | $9.00 | $8.19 | $7.97 | $7.69 | $7.48 | $6.76 | $5.03 | $4.67 | $3.88 | $3.00 | $2.46 | $1.78 | $1.55 | $1.34 | $1.00 |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| EPS (quarterly) | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (EPS) | $10.91 | $6.05 | $4.50 | $5.96 | $6.53 | $6.33 | $6.12 | $4.49 |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
More NVO metrics: Revenue · Gross Profit · Operating Income · Net Income · EBITDA · Free Cash Flow · Shares Outstanding
All NVO financial statements → Interactive NVO charts →
About TickerBase · Data methodology & sources